As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.
Jun '25 |
+/-
%
|
||
Revenue | 180 180 |
4%
4%
|
|
Gross Profit | 138 138 |
2%
2%
|
|
EBITDA | 102 102 |
2%
2%
|
EBIT (Operating Income) EBIT | 101 101 |
2%
2%
|
Net Profit | 82 82 |
2%
2%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.
Head office | United States |
CEO | Diem Nguyen |
Employees | 46 |
Founded | 1995 |
Website | www.siga.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.